The combination of the farnesyl transferase inhibitor lonafarnib and the proteasome inhibitor bortezomib induces synergistic apoptosis in human myeloma cells that is …
The identification of signaling pathways critical to myeloma growth and progression has
yielded an array of novel agents with clinical activity. Multiple myeloma (MM) growth is IL-6 …
yielded an array of novel agents with clinical activity. Multiple myeloma (MM) growth is IL-6 …
[PDF][PDF] The combination of the Farnesyl Transferase Inhibitor (Lonafarnib) and the Proteasome Inhibitor (Bortezomib) Induces Synergistic Apoptosis in Human …
E David, SY Sun, EK Waller, FR Khuri, S Lonial - researchgate.net
myeloma cells that is associated with down-regulation of p-AKT human proteasome
inhibitor (Bortezomib) induces synergistic apopt Page 1 doi:10.1182/blood-2005-06-2584 …
inhibitor (Bortezomib) induces synergistic apopt Page 1 doi:10.1182/blood-2005-06-2584 …
The combination of the farnesyl transferase inhibitor lonafarnib and the proteasome inhibitor bortezomib induces synergistic apoptosis in human myeloma cells that is …
E David, SY Sun, EK Waller, J Chen, FR Khuri, S Lonial - Blood, 2005 - europepmc.org
The identification of signaling pathways critical to myeloma growth and progression has
yielded an array of novel agents with clinical activity. Multiple myeloma (MM) growth is IL-6 …
yielded an array of novel agents with clinical activity. Multiple myeloma (MM) growth is IL-6 …
The combination of the farnesyl transferase inhibitor lonafarnib and the proteasome inhibitor bortezomib induces synergistic apoptosis in human myeloma cells that is …
E David, SY Sun, EK Waller, J Chen, FR Khuri… - …, 2005 - pubmed.ncbi.nlm.nih.gov
The identification of signaling pathways critical to myeloma growth and progression has
yielded an array of novel agents with clinical activity. Multiple myeloma (MM) growth is IL-6 …
yielded an array of novel agents with clinical activity. Multiple myeloma (MM) growth is IL-6 …
[HTML][HTML] The combination of the farnesyl transferase inhibitor lonafarnib and the proteasome inhibitor bortezomib induces synergistic apoptosis in human myeloma …
E David, SY Sun, EK Waller, J Chen, FR Khuri, S Lonial - Blood, 2005 - Elsevier
The identification of signaling pathways critical to myeloma growth and progression has
yielded an array of novel agents with clinical activity. Multiple myeloma (MM) growth is IL-6 …
yielded an array of novel agents with clinical activity. Multiple myeloma (MM) growth is IL-6 …
[PDF][PDF] The combination of the Farnesyl Transferase Inhibitor (Lonafarnib) and the Proteasome Inhibitor (Bortezomib) Induces Synergistic Apoptosis in Human …
E David, SY Sun, EK Waller, FR Khuri, S Lonial - academia.edu
myeloma cells that is associated with down-regulation of p-AKT human proteasome
inhibitor (Bortezomib) induces synergistic apopt Page 1 doi:10.1182/blood-2005-06-2584 …
inhibitor (Bortezomib) induces synergistic apopt Page 1 doi:10.1182/blood-2005-06-2584 …